Treatment | Blocks | Survival (%) | CGRP (%) |
---|---|---|---|
NB5 | — | 109.7 ± 8.2 | 7.0 ± 0.6 |
NB50 | — | 85.3 ± 2.2 | 26.4 ± 1.6 |
NB50 + tetrodotoxin | Na+ channel | 81.4 ± 3.6 | 21.4 ± 1.6 |
NB50 + ω-conotoxin | N-type Ca2+ channel | 86.4 ± 3.6 | 19.1 ± 2.3* |
NB50 + verapamil | L-type Ca2+ channel | 89.6 ± 1.6 | 14.4 ± 0.7** |
NB50 + nifedipine | L-type Ca2+ channel | 85.9 ± 0.6 | 12.0 ± 0.7*** |
E14.5 DRG cells were maintained in NB50 medium with 1 μm tetrodotoxin, 2.5 μm ω-conotoxin GVIA, 10 μm verapamil, or 10 μm nifedipine for 8 d before immunocytochemistry for CGRP. The percentage of CGRP-IR and surviving neurons was determined. Cell survival in all conditions was good, with 80% of neurons alive after 8 d (unpairedt test, p > 0.20). CGRP expression was inhibited by nifedipine, verapamil, and ω-conotoxin GVIA. In contrast, tetrodotoxin had no effect (unpaired t test,p = 0.14). Similar values were obtained in at least three independent experiments for each condition. Data are mean and SEM. *p < 0.05; **p < 0.01; ***p < 0.0001.